Patients with chronic heart failure had increased bowel wall thickness and significantly higher large intestinal permeability (0.62% vs 0.20%, p=0.03) compared to control subjects.
Case-Control (n=44)
Patients with chronic heart failure exhibit significant alterations in intestinal morphology, permeability, and bacterial biofilm, which may contribute to systemic inflammation and malnutrition.
Absolute Event Rate: 0.62% vs 0.2%
p-value: p=0.03
OBJECTIVES We evaluated morphology and function of the gut in patients with chronic heart failure (CHF). BACKGROUND Intestinal translocation of bacterial endotoxin may contribute to the inflammatory state observed in patients with CHF. The morphology and function of the gut may be abnormal. METHODS We studied 22 patients with CHF (age 67 +/- 2 years, left ventricular ejection fraction LVEF 31 +/- 1%, New York Heart Association functional class 2.3 +/- 0.1, peak VO2 15.0 +/- 1.0 ml/kg/min) and 22 control subjects (62 +/- 1 years, LVEF 68 +/- 2%, peak VO2 24.7 +/- 1.3 ml/kg/min). Bowel wall thickness was assessed by transcutaneous sonography, small intestinal permeability by the lactulose-mannitol test, passive carrier-mediated transport by D-xylose test, large intestinal permeability by sucralose test (5- and 26-h urine collection, high-performance liquid chromatography), and mucosal bacterial biofilm by fluorescence in situ hybridization in biopsies taken during sigmoidoscopy. RESULTS Chronic heart failure patients, compared with control patients, showed increased bowel wall thickness in the terminal ileum (1.48 +/- 0.16 mm vs. 1.04 +/- 0.08 mm), ascending colon (2.32 +/- 0.18 mm vs. 1.31 +/- 0.14 mm), transverse colon (2.19 +/- 0.20 vs. 1.27 +/- 0.08 mm), descending colon (2.59 +/- 0.18 mm vs. 1.43 +/- 0.13 mm), and sigmoid (2.97 +/- 0.27 mm vs. 1.64 +/- 0.14 mm) (all p < 0.01). Chronic heart failure patients had a 35% increase of small intestinal permeability (lactulose/mannitol ratio: 0.023 +/- 0.001 vs. 0.017 +/- 0.001, p = 0.006), a 210% increase of large intestinal permeability (sucralose excretion: 0.62 +/- 0.17% vs. 0.20 +/- 0.06%, p = 0.03), and a 29% decrease of D-xylose absorption, indicating bowel ischemia (26.7 +/- 3.0% vs. 37.4 +/- 1.4%, p = 0.003). Higher concentrations of adherent bacteria were found within mucus of CHF patients compared with control subjects (p = 0.007). CONCLUSIONS Chronic heart failure is a multisystem disorder in which intestinal morphology, permeability, and absorption are modified. Increased intestinal permeability and an augmented bacterial biofilm may contribute to the origin of both chronic inflammation and malnutrition.
Sandek et al. (Mon,) conducted a case-control in Chronic heart failure (n=44). Chronic heart failure vs. Control subjects was evaluated on Large intestinal permeability (sucralose excretion) (p=0.03). Patients with chronic heart failure had increased bowel wall thickness and significantly higher large intestinal permeability (0.62% vs 0.20%, p=0.03) compared to control subjects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: